<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

“Rivaroxaban was clearly beneficial in patients with chronic kidney disease and was particularly effective at reducing the risk of limb events in patients — that is, acute limb ischemia and above-the-knee amputation,” Judith Hsia, MD, with the department of medicine at University of Colorado School of Medicine, told Healio.